Nasdaq:ACHV

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

September 11, 2025 17:01 ET  | Source: Achieve Life Sciences SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE)…

3 months ago

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

June 26, 2025 23:43 ET  | Source: Achieve Life Sciences SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE)…

5 months ago